Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
CXLn01NaDyN2sRME
